Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Inner Mongolia Furui Medical Science Co (SZSE:300049) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Inner Mongolia Furui Medical Science Co Net Margin % Related Terms
Inner Mongolia Furui Medical Science Co Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inner Mongolia Furui Medical Science Co Net Margin % Chart
Inner Mongolia Furui Medical Science Co Annual Data
SZSE:300049 vs VRTX, REGN, RVMD: Net Margin % Comparison
For the Biotechnology subindustry, Inner Mongolia Furui Medical Science Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Inner Mongolia Furui Medical Science Co Net Margin % vs Biotechnology Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Inner Mongolia Furui Medical Science Co (SZSE:300049) has a Net Margin % of 8.15% as of Jun. 2026. Net margin is the ratio of total net income to net sales. View historical data on Inner Mongolia Furui Medical Science Co and its competitors. This is near median its historical median of 8.60. Over the past decade, Inner Mongolia Furui Medical Science Co's Net Margin % has ranged from 4.08 to 14.64. According to the industry distribution chart, Inner Mongolia Furui Medical Science Co ranks #195 out of 944 companies in the Biotechnology industry, placing it in the top 20.7%.
Is Inner Mongolia Furui Medical Science Co's Net Margin % too high?
Inner Mongolia Furui Medical Science Co's current Net Margin % of 8.15% is near median its 10-year median of 8.60. Over the past 10 years, this metric has ranged from a low of 4.08 to a high of 14.64. Based on the distribution chart, Inner Mongolia Furui Medical Science Co ranks #195 out of 944 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Inner Mongolia Furui Medical Science Co has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Inner Mongolia Furui Medical Science Co's Net Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Inner Mongolia Furui Medical Science Co ranks #195 out of 944 companies for Net Margin %. This places Inner Mongolia Furui Medical Science Co in the top 21% of its industry — outperforming the majority of peers. Historically, Inner Mongolia Furui Medical Science Co's own Net Margin % has ranged from 4.08 to 14.64 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Inner Mongolia Furui Medical Science Co and its competitors. Inner Mongolia Furui Medical Science Co's current Net Margin % is 8.15%, which is near median its own 10-year median of 8.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inner Mongolia Furui Medical Science Co stock overvalued right now?
Based on GuruFocus' analysis, Inner Mongolia Furui Medical Science Co (SZSE:300049) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥65.97, compared to a current price of ¥43.94 — trading 33.4% below its estimated fair value. The current Net Margin % is 8.15%, which is near median its 10-year median of 8.60. Inner Mongolia Furui Medical Science Co's overall GF Score™ is 81/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Inner Mongolia Furui Medical Science Co (SZSE:300049), the current Net Margin % is 8.15% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Inner Mongolia Furui Medical Science Co (SZSE:300049) Overvalued in 2026?
Based on GuruFocus' analysis, Inner Mongolia Furui Medical Science Co stock appears to be undervalued.
The current stock price of ¥43.94 is trading 33.4% below its estimated GF Value™ of ¥65.97.
GuruFocus considers Inner Mongolia Furui Medical Science Co to be Significantly Undervalued.
Key valuation signals for SZSE:300049:
Net Margin %: 8.15% (near median its 10-year median of 8.60)
GF Value™: ¥65.97 vs. price of ¥43.94 (33.4% below fair value)
No single metric tells the full story. See the SZSE:300049 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Inner Mongolia Furui Medical Science Co Ltd is a China based medical service platform company. It provides disease diagnosis, drug treatment and chronic disease management centered on the liver disease field. The product portfolio of the company includes tablets, capsules, and plaster. In addition, the company is also engaged in providing health-care services.
81GF Score
Get the complete analysis for SZSE:300049
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:300049 has been successfully added to your 
